An official website of the United States government

This repository is under review for potential modification in compliance with Administration directives.

Publication Information

PubMed ID
Public Release Type
Journal
Publication Year
2011
Affiliation
ivision of Endocrinology, University of Miami, Miami, Florida, USA. jsosenko@med.miami.edu
Authors
Cuthbertson D, Diabetes Prevention Trial–Type 1 and Type 1 Diabetes TrialNet Study Groups, Eisenbarth G, Krischer JP, Orban T, Palmer JP, Schatz DA, Skyler JS, Sosenko JM, Yu L
Studies
Citation
Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Cuthbertson D, Yu L, Schatz DA, Orban T, Eisenbarth G, Diabetes Prevention Trial–Type 1 and Type 1 Diabetes TrialNet Study Groups. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants. Diabetes Care 2011 Nov;34(11):2435-7. Epub 2011 Sep 12.

Abstract

We examined changes in GAD65 and ICA-512 autoantibodies (GADA and IA-2A) during progression to type 1 diabetes (T1D).